A retrospective study revealed no significant difference in 36-month progression-free survival and renal function outcomes in patients with small renal masses.
Significant reduction also seen in obesity-related cancer incidence and in cancer mortality after bariatric surgery
Clinicians should closely monitor patients’ blood pressure after nephrectomy, according to investigators.
Investigators believe their study is the first to demonstrate the adverse impact of LVI on overall survival in patients with surgically treated renal cell carcinoma.
Benefits seen for head/neck, stomach, pancreatic, liver, colon, kidney, and lung cancer
In a study, the Selection for Cytoreductive Nephrectomy (SCREEN) score demonstrated superiority in predicting first-year mortality among patients with metastatic kidney cancer compared with an IMDC model.
The Kidney Cancer Risk Equation for predicting post-nephrectomy ESKD builds on the ubiquitous Kidney Failure Risk Equation and is easy to use, according to investigators.
A study revealed no significant difference in the incidence of left ventricular systolic dysfunction between patients aged 18-39 years and older patients.
At ASCO 2023, investigators reported results from phase 3 trials that could improve therapeutic approaches to bladder, prostate, and kidney cancer.
Strategies include dose rounding and vial sharing, as well as weight-based dosing